The polymerase chain reaction (PCR) and techniques based on this method, were advanced by Kary Mullis in 1983, for which he later received the Nobel Prize. Since then, PCR has grown and evolved out of all recognition and it is now the most widely used technique in molecular biology, biochemistry and medicine.
The numbers of applications for PCR are considerable and include sequencing, fingerprinting, cloning, disease research, diagnostics, drug discovery, disease biomarkers and forensics. Such has been the impact of this technique in the life science field that some observers have referred to two epochs – “Before PCR” and “After PCR”.¹
Bucking current economic trends, PCR is growing by more than 13% per year and by 2015 global markets are expected to exceed $27 billion.² This is almost three times greater than the global markets for microarray, flow cytometry and mass spectrometry put together.
A recent market study (PCR 2012) by...